Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2010-05-13 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
2009年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2009 Annual General Meeting (AGM) resolution announcement for Beijing SL Pharmaceutical Co., Ltd. It details the convening and attendance of the 2009 AGM, the proposals reviewed and approved by shareholders, voting results, independent director reports, and legal witness statements. The content focuses on the official announcement of the AGM resolutions and voting outcomes rather than the full AGM materials or presentations. The document length is relatively short (2646 characters), and it primarily reports the results of the shareholder meeting. Therefore, it fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2010-05-13 Chinese
2010年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2010 First Quarter Quarterly Report" of Beijing Shuanglu Pharmaceutical Co., Ltd. It contains detailed financial data including balance sheets, profit and loss statements, and explanations of financial changes for the first quarter of 2010. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2010
2010-04-22 Chinese
2009年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report for the fiscal year 2009 of Beijing SL Pharmaceutical Co., Ltd. It includes an auditor's opinion, references to accounting standards, and detailed financial statements such as balance sheets and income statements. The presence of an auditor's opinion and detailed financial data indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial statements and audit opinions, not just an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2009
2010-04-22 Chinese
2010年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2010 First Quarter Quarterly Report" of Beijing SL Pharmaceutical Co., Ltd. It contains detailed financial data for the first quarter of 2010, including assets, equity, revenue, net profit, cash flow, earnings per share, and other financial indicators. It also includes explanations of significant changes in financial items, shareholder information, and investment details. The report is unaudited but signed by company officers, indicating it is a formal quarterly financial report. The length is over 6,000 characters and contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2010
2010-04-22 Chinese
年报信息披露重大差错责任追究制度（2010年4月）
Governance Information Classification · 95% confidence The document is titled as a responsibility accountability system related to major errors in annual report information disclosure for Beijing Shuanglu Pharmaceutical Co., Ltd. It outlines principles, responsibilities, and disciplinary measures for errors in annual report disclosures. It does not contain actual financial data or the annual report itself but rather a governance and compliance policy related to annual report disclosures. The document is relatively short (1584 characters) and focuses on internal rules and accountability mechanisms rather than presenting financial results or audit findings. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2010-04-22 Chinese
2009年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2009年度内部控制自我评价报告' which translates to '2009 Annual Internal Control Self-Evaluation Report'. It is issued by the company's board and audit committee, referencing compliance with various laws and regulations related to internal control and corporate governance. The content extensively discusses the company's internal control environment, risk assessment, control activities, information and communication, and internal supervision. It includes detailed descriptions of governance structures, control measures, audit activities, and self-evaluation results for the year 2009. The document is comprehensive and contains substantive information about the company's internal control system and its effectiveness over the fiscal year. This type of report is typically classified as an Audit Report / Information (AR) because it focuses on internal control evaluation and audit committee assessments rather than being a full annual report (10-K) or a regulatory announcement. The length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2009
2010-04-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.